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Several species of eukaryotic organisms living in the high mountain areas of Armenia with 24 
naturally-occurring levels of radiation have high adaptive responses to radiation. We speculate 25 
on the role of the gastrointestinal microbiota in this protection against radiation. Therefore, 26 
seventeen microorganisms with high antagonistic activities against several multi-drug resistant 27 
pathogens were isolated from the human and animal gut microbiota, as well as from traditional 28 
Armenian fermented products. These strains were tested in vivo on Wistar rats to determine their 29 
ability to protect the eukaryotic host against radiation damages. The efficiency of the probiotics’ 30 
application and the dependence on pre- and post-radiation nutrition of rats were described.  31 
The effects of Lactobacillus rhamnosus Vahe, isolated from a healthy breastfed infant, and 32 
Lactobacillus delbrueckii IAHAHI, isolated from the fermented dairy product matsuni, on the 33 
survival of irradiated rats, and their blood leucocyte and glucose levels, were considered to be 34 
the most promising, based on this study’s results. 35 
 36 
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There is an emerging interest in the effects of natural radiation (NR) (radioactivity in the rocks 40 
and soil of the earth's crust, cosmic radiation, etc.) on the health of humans and other animals [1-41 
4]. The potential risk of radiation accidents is also increasing, especially in developing or 42 
politically unstable countries or those with aging nuclear infrastructure. At the same time, 43 
exposures to doses of radiation of 1-10 Gy, defined as moderate-dose radiation, may occur 44 
during the course of radiation therapy or as the result of radiation accidents or 45 
nuclear/radiological terrorism alone or in conjunction with bioterrorism. The resulting radiation 46 
injuries would be due to a series of molecular, cellular, tissue, and organism-level processes [5].  47 
Radiation damage to bone marrow results in the loss of hematopoietic cells, followed by 48 
leukopenia and thrombocytopenia. Peripheral white blood cells (WBC) are known to be very 49 
radiosensitive; they readily undergo apoptosis, with some cells being affected 24 h after 50 
irradiation [6], while radiation damage to small bowel tissue can cause acute or chronic 51 
radiation enteritis with bloating, nausea, fecal urgency, diarrhea, and rectal bleeding [7]. A dose-52 
dependent decrease in WBC counts in experimental animals, especially in mice exposed to high- 53 
and low-dose-rate proton and γ radiation was reported [8, 9]. Probiotics are defined as live 54 
microorganisms which, when administered in adequate amounts, confer a health benefit on the 55 
host [10]. Several clinical trials and experimental studies suggest that probiotics may be used as 56 
biotherapeutic agents for the prevention and treatment of gastrointestinal diseases [11-14]. 57 
Associations between the characteristics of host blood and gut bacteria for humans [15, 16, 17], 58 
as well as for animals [18, 19], were also reported. Previously, the effects of potential probiotics 59 
L. rhamnosus Vahe, L. delbrueckii IAHAHI, and L. plantarum ZPZ in male Wistar rats’ small 60 
intestine were studied using a neutral comet assay after seven days of feeding with probiotic 61 
strains [20]. Other studies have reported that probiotics may be effective in the morphological 62 
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shortening of small intestinal mucosa damaged by radiation less than or equal to 15 Gy [21].  63 
Cell-free supernatants (CFS) of probiotics might contain vitamins, potential GI radioprotectors 64 
[22], lactic acid, hydrogen peroxide, diacetyl, reuterin, and bacteriocins [23-25] providing 65 
immunomodulatory effects [26]. It is possible that the pre- and post-treatment effects of specific 66 
CFS compounds, including vitamins [27] as well as vitamin-producing probiotics, on animals’ 67 
survival might be different. 68 
This investigation was aimed at the evaluation of seventeen putative probiotic strains, having 69 
antagonistic potential against several human and animal pathogens, on their ability to protect 70 
against 4.5 - 20 Gy radiation damages. The pre- and post-treatment effects of these strains on the 71 
survival of whole-body X-ray irradiated rats and rats’ blood characteristics, such as WBC and 72 
blood glucose levels (BGL), were evaluated in vivo.  73 
 74 
Materials and Methods 75 
Bacterial strains 76 
Seventeen putative probiotic lactobacilli (please see the supplementary material), including L. 77 
rhamnosus Vahe and L. plantarum ZPZ from breastfeeding infants, L. delbrueckii IAHAHI from 78 
matsuni, L. acidophilus DDS®-1 (Lacto-G, a marketed symbiotic formulation) [20] and 79 
probiotic Narine (L. acidophilus INMIA 9602 Er-2 strain 317/402) [13, 14, 28] were obtained 80 
from the culture collections of the International Association for Human and Animals Health 81 
Improvement and the Armenian National Agrarian University. Bacterial strains were cultured in 82 
de Man, Rogosa, and Sharpe (MRS) broth and on MRS agar (ThermoFisher Scientific, Waltham, 83 
MA, USA). When required, Oxoid™ Endo Agar (ThermoFisher Scientific),  and a VITEK® 2 84 
compact ID/AST instrument (bioMérieux, Craponne, France) and conventional PCR were used 85 
to identify lactobacilli, including L. casei, L. paracasei, and L. rhamnosus [29], L. plantarum 86 
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[30, 31], L. delbrueckii subsp. bulgaricus [32], L. crispatus, L. fermentum [33] and L. helveticus 87 
[34] were used to identify the bacterial cells. 88 
 89 
Whole-genome sequencing 90 
Lactobacilli were cultivated in MRS broth at 37°C for 24 h. Genomic DNA was extracted using 91 
a diaGene kit (diaGene, Diaem, Moscow, Russia).  92 
In order to generate draft genome sequences, the DNA was first subjected to partial enzymatic 93 
hydrolysis using a NEBNext Fast DNA Fragmentation and Library Preparation Kit for Ion 94 
Torrent (New England Biolabs, Ipswich, MA, USA). The randomly generated genomic DNA 95 
fragments were ligated to P2 and A1 adapters, followed by isolation of 490 bp fragments using 96 
E-gel and PCR amplification. The generated sequencing library was then analyzed using a High 97 
Sensitivity DNA kit with BioAnalyser 2100 (Agilent, Santa Clara, CA, USA) for precise 98 
estimation of DNA sizes and concentrations. A ssequencing template was prepared using the 99 
IonTorrent One Touch system (ThermoFisher Scientific) and Ion PGM Hi-Q™ View OT2 Kit 100 
(ThermoFisher Scientific), followed by enrichment for positive Ion Sphere Particles using One 101 
Touch ES enrichment system (ThermoFisher Scientific). The sequencing reaction was conducted 102 
on the IonTorrent PGM with 316v2 chip using Ion PGM Hi-QTM View Sequencing Kit with 850 103 
sequencing flows, as recommended by the manufacturer for achieving the maximum read 104 
lengths.   105 
 106 
Genome annotation and bioinformatics analysis 107 
Bacterial identification was performed via the analysis of 16S rRNA sequences, which were 108 
generated via read mapping onto relevant reference 16S rRNA sequences followed by extraction 109 
of consensus sequences using CLC Genomics Workbench software, ver. 7.5. The derived 110 
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sequences were run via NCBI BlastN server and the bacterial 16S rRNA sequence database. A 111 
16S rRNA-based bacterial identification server EZBiocloud was also used [35]. The genome 112 
assembly was conducted using three programs: MIRA, SPAdes (as IonTorrent Server plugins), 113 
and the CLC de novo assembly program. The results were compared using the following 114 
parameters: total number of contigs, total genome sizes, and N50 values. The best assemblies 115 
(generated by SPAdes, ver. 5.0.0.0) were used for deposition into the GenBank and further 116 
analysis. The Whole Genome Shotgun projects have been deposited at DDBJ/EMBL/GenBank 117 
under the accession numbers VRTP00000000 (L. delbrueckii IAHAHI), VRTQ00000000 118 
(L. rhamnosus Vahe), and VRTR00000000 (L. plantarum ZPZ). The versions described in this 119 
paper are VRTP01000000 (L. delbrueckii IAHAHI), VRTQ01000000 (L. rhamnosus Vahe), and 120 
VRTR01000000 (L. plantarum ZPZ). The draft genome sequences were annotated using the 121 
NCBI GenBank annotation pipeline [36] and RAST (Rapid Annotation using Subsystem 122 
Technology) tools [37].  123 
 124 
Experimental rats 125 
Four hundred healthy adult male Wistar rats in the weight range of 250-300 g were randomly 126 
placed into the following groups for the investigation of  L. rhamnosus Vahe and L. delbrueckii 127 
IAHAHI supplementation, which are the most promising strains among studied lactobacilli for 128 
protection against  4.5 - 20 Gy radiation damages: 129 
1. Controls non-irradiated: control (n=8), control-placebo (n=8), control probiotic Vahe (n=8), 130 
control probiotic IAHAHI (n=8).  131 
2. Controls irradiated with doses: 4.5 Gy (n=8), 5.5 Gy (n=8), 12.5 Gy (n=8) and 20 Gy (n=8) 132 
probiotic Vahe. 133 
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3. Irradiated with 5.5 Gy probiotic groups (n=272) (rats were fed with probiotics before and after 134 
the irradiation), sixteen rats were used for each probiotic. 135 
4. Irradiated with 5.5 Gy CFS groups (rats were fed with CFS from probiotic Vahe either before, 136 
after, or throughout the irradiation) (n=24). 137 
5. Irradiated with 12.5 Gy (n=8) and 20 Gy (n=8) CFS groups (rats were fed with CFS from 138 
probiotic Vahe prior to irradiation). 139 
6. Irradiated with 5.5 Gy (n=8), 12.5 Gy (n=8), and 20 Gy (n=8) probiotic IAHAHI groups (rats 140 
were fed with probiotic IAHAHI for 7 days after the appropriate dose of irradiation (Figure 1).  141 
During the next cycle of investigations performed for the statistical analysis, there were no 142 
“placebo” rats because of the absence of valid differences between the research data for control 143 
and placebo group rats.  144 
The rats were housed in standard wire cages with a constant temperature of 20±2 ℃, and with a 145 
cycle of 12 h of light and 12 h of darkness. Rats were fed with standard rations of chow and 146 
sterilized water by oral gavage. Control placebo rats received 2 mL of physiological solution 147 
only, while control probiotic rats were fed with standard chow and received 2 mL of overnight 148 
bacterial cultures in physiological solution (temperature: 20–22 °C), containing 1.0×108 colony-149 
forming units (CFU) of the probiotic, and rats from the irradiated-probiotic group were given an 150 
appropriate feeding cannula for seven days prior to receiving a 4.5-20 Gy irradiation. CFS was 151 
prepared from 2 mL of overnight bacterial culture by centrifugation (8,000 X g for 5-7 min).  152 
Following treatment and irradiation, rats were anesthetized with an intraperitoneal injection of 153 
100 mg/kg of ketamine hydrochloride and sacrificed. 154 
 155 
Irradiation  156 
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Whole-body X-ray irradiation was performed using a RUM-17 therapeutic X-ray machine 157 
(Mosrentgen, Moscow, Russia); (technical specifications- dose levels: 4.5 Gy, 5.5 Gy, 12,5 Gy, 158 
and 20 Gy, dose rate: 1.43 Gy/min, height of a X-ray tube over an object: 50 cm, current: 15 mA, 159 
180 kV and exposition time: 3.1 min, 3.85 min, 8.74 min, and 13.99 min accordingly).  160 
 161 
BGLs 162 
BGLs were measured according to the standard God-Pod colorimetric method using Stat Fax 163 
3300 (Awareness Technologies, Westport, CT, USA). For the estimation of total WBCs after the 164 
seventh day of irradiation, a hemocytometer (BLAUBRAND® Neubauer improved, Sigma-165 
Aldrich, St. Louis, MO, USA) was used as described previously [13].  166 
 167 
Statistical analysis 168 
Statistical processing of data was performed using the Mann-Whitney’s and Student's t-test (QI 169 
Macros SPC Software for MS Excel, Southfield, MI, USA). A probability of P < 0.05 was 170 
considered as statistically significant.  171 
 172 
Results 173 
According to our study, seventeen putative probiotics have shown different impacts on irradiated 174 
rats; furthermore, probiotic administration had different effects (positive, neutral, or negative) 175 
before (Groups 3.1-3.17) and after (Groups 3.2-3.27) the rats’ irradiation. Data on the effects of 176 
the putative probiotic L. rhamnosus Vahe and L. delbrueckii IAHAHI as potential radio-177 
protective agents are presented below. There were no statistically significant differences between 178 
the viability of the control and placebo group rats. Also, there were no statistically significant 179 
differences between the 12.5 Gy (Group 2.3) and 20 Gy (Group 2.4) whole-body single-dose X-180 
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ray irradiated rats’ viabilities in the first day of irradiation, but the viabilities were different 181 
between the 12.5/20 Gy and 5.5 Gy X-ray irradiated animals (Group 2.2) (87.5±4.38 vs. 100±5, 182 
P<0.05) (Figure 2). The percentages of live rats were significantly different on the third day of 183 
irradiation: 75±3.8 (5.5 Gy), 62.5±3.13 (12.5 Gy) and 37.5±1.9 (20 Gy) (Figure 2).  184 
 185 
Radio-preventive effects of potential probiotic L. rhamnosus Vahe on irradiated rats: dose-186 
mortality relationship in vivo 187 
The effects of strain L. rhamnosus Vahe on the viability of rats irradiated with 5.5 Gy X-ray are 188 
presented in Figure 3. All animals were alive the first day after the irradiation. The “probiotic-fed 189 
irradiated rats” (Groups 3.1-3.17; Figure 1) and “CFS-fed irradiated rats” groups (Group 4.1) 190 
receiving an appropriate feeding cannula for seven days prior to receiving 5.5 Gy irradiation 191 
showed similar viability during the seven days after the irradiation. The effects of the irradiation 192 
dose on rats’ survival were detectable after the first day of irradiation and increased significantly 193 
over the subsequent five to six days. There was a 1.5-fold increase in viability in the presence of 194 
L. rhamnosus Vahe or its CFS compared with the irradiated control group of rats (Figure 3). The 195 
group of rats that received CFS both before and after the irradiation (Group 4.3) showed high 196 
viability on the third and fourth days in comparison with the other groups (Figure 3). However, 197 
half of these rats stayed alive after the sixth day of irradiation in comparison with 37.5 % live 198 
rats in the irradiated group with 5.5 Gy (Figure 3). 199 
The effect of L. rhamnosus Vahe on the viability of rats irradiated with 12.5 Gy (Group 5.1)    200 
and 20 Gy X-ray (Group 5.2) is presented in Figure 4. There was no statistically significant 201 
difference in viabilities one day after irradiation between the control groups of rats (Groups 2.3 202 
and 2.4) and those which received CFS before irradiation (Groups 2.3 vs. 5.1 and Groups 2.4 vs. 203 
5.2) (Figure 4). Half of the 20 Gy X-ray irradiated rats died after 2.5 days, and after the fifth day, 204 
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there were no live rats in this group (Group 2.4) (Figure 4). Except for the 20 Gy X-ray irradiated 205 
rats, the viabilities of other research groups were similar; half of the animals from each of these 206 
groups died on the fourth day of irradiation. The number of mortalities was different in the 207 
groups of irradiated rats after the fourth day of irradiation. The number of live rats on the sixth 208 
day after irradiation was significantly lower in the 12.5 Gy irradiated group than that in the 12.5 209 
Gy CFS group (12.5±0.62 vs. 50±2.5, P<0.05). Approximately 16.7 % of the 20 Gy irradiated 210 
CFS-fed rats (Group 5.2) were alive after the fifth day of irradiation (Figure 4). 211 
Thus, compared with the control irradiated rats, the viabilities of the rats in the  CFS-fed rats 212 
groups was increased: 66.7±1.3 vs. 37, P<0.05 (5.5 Gy) (Figure 3), 50±2.5 vs 12.5±0.62, P<0.05 213 
(12.5 Gy) and 16.7±0.67 vs 0, P<0.05 (20 Gy) after the sixth day of irradiation (Figure 4).  214 
 215 
Radio-preventive effects of L. rhamnosus Vahe on irradiated rats: WBC counts and BGLs.  216 
In vivo observations revealed a significant decrease in total WBC after the seventh day of 217 
irradiation with 4.5 Gy in comparison with the untreated control and placebo group rats 218 
((0.80±0.07) x109 CFU /L vs. (7.12±0.39) x109 CFU/L (untreated control group) and (6.84±0.77) 219 
x109 CFU/L (placebo group); P< 0.05). The administration of probiotic increased the WBC 220 
counts ((2.00±0.04) x109 CFU/L).  221 
The WBC count decreased significantly in live rats irradiated with 5.5 Gy ((0.57±0.03) x109 222 
CFU/L vs. (0.80±0.07) x109 CFU/L; P< 0.05) and remained unchanged in live rats irradiated 223 
with 12.5 Gy ((0.57±0.03) x109 CFU/L vs. (0.59±0.01) x109 CFU/L; P> 0.05) (Table 1).  224 
The investigations on the impact of the probiotic on 4.5 Gy irradiated rats’ BGLs did not reveal 225 
any changes in this criterion for rats given the placebo (Group 1.2) as compared with the control 226 
untreated group (Group 1.1) ((6.73±0.33) mM/L vs. (7.26±0.19) mM/L; P>0.05) (Table 2). In 227 
addition, the 4.5 Gy irradiation dose didn’t change the BGL on the seventh day after irradiation 228 
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((6.735±0.3) mM/L vs. (7.26±0.19) mM/L; P>0.05). Probiotic administration did not 229 
significantly increase the BGL level on the seventh day of irradiation (the level still was in a 230 
physiologically-normal range) (8.119±0.2 mM/L vs. 7.26±0.19 mM/L; P < 0.05), the rats fed the 231 
probiotic prior to 4.5 Gy irradiation were not different from the untreated controls by their BGL 232 
((7.707±0.16) mM/L vs. (7.26±0.19) mM/L; P>0.05) after the seventh day of irradiation (Table 233 
2).  234 
An increase in irradiation dose from 4.5 to 12.5 Gy did not have an effect on rats’ BGL. 235 
Moreover, the results of investigations show that the probiotic and its CFS did not significantly 236 
decrease the BGL of rats (the level still was in the normal range). 237 
 238 
Radio-protective effects of a potential probiotic L. delbrueckii IAHAHI on irradiated rats: 239 
in vivo dose-mortality relationship  240 
The irradiation dose-viability effects on Wistar rats are presented in Figure 5. According to the 241 
investigations, administration of the probiotic after irradiation significantly increased the 242 
viability of 5.5 Gy to 20 Gy irradiated rats, while there were no significant effects when the rats 243 
were fed this probiotic prior to irradiation. On the seventh day after irradiation, the number of 244 
irradiated rats in the probiotic group was higher by approximately 22-24% (5.5 Gy), 25-26% 245 
(12.5 Gy), and 18-19% (20 Gy) compared with the untreated group (Figure 5).  246 
 247 
Radio-protective effects of probiotic L. delbrueckii IAHAHI on irradiated rats: WBC and 248 
BGL 249 
Table 3 presents the results of L. delbrueckii IAHAHI administration on 4.5 Gy X-ray irradiated 250 
rats’ BGLs. In comparison with the untreated control rats, BGLs decreased in the probiotic group 251 
((6.594±0.2) mM/L vs. 7.26±0.19 mM/L, P<0.05).  Administration of the probiotic after 4.5 Gy 252 
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X-ray irradiation of rats didn’t affect BGL ((7.62±0.54) mM/L vs. 7.26±0.19 mM/L, P>0.05). 253 
Parallel to this, this group of rats was also characterized by a statistically significant increase in 254 
WBC in comparison with the irradiated controls (Figure 6). 255 
 256 
Whole-genome sequencing of lactobacilli 257 
The data given in Table 4 show that the genome sizes and GC contents of all three strains are in 258 
agreement with the values of relevant completely sequenced genomes.  259 
Vitamin production  260 
The number of genes involved in the production of vitamins and cofactors in strains L. 261 
rhamnosus Vahe and L. delbrueckii IAHAHI is only about a half of the number found in strain L. 262 
plantarum ZPZ (61 and 52 vs. 117, respectively, Figure 7). All three strains appear to have the 263 
ability to produce riboflavin (vitamin B2), biotin (vitamin B8 or vitamin BH), folate (folic 264 
acid, folacin, and vitamin B9), and pyridoxine (vitamin B6), in some cases. Additionally, L. 265 
delbrueckii IAHAHI and L. plantarum ZPZ both contain genes involved in the production of 266 
thiamin (vitamin B1). L. rhamnosus Vahe and L. plantarum ZPZ also contain genes required for 267 
the production of 5-formyltetrahydrofolate cyclo-ligase-like protein (5-FCL like protein) and 268 
those involved in heme and siroheme biosynthesis (Figure 7). L. plantarum ZPZ is also a 269 
potential producer of a molybdenum cofactor, which is essential for human development [38] 270 
(Figure 7).  271 
  272 
Discussion 273 
The possible effects of the potential probiotics L. rhamnosus Vahe and L. delbrueckii IAHAHI 274 
on the characteristics of blood and the small intestine of irradiated rats have been discussed 275 
previously [39]. While there is a decrease in the viability of L. rhamnosus Vahe cells by 15-57% 276 
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when exposed to 50-150 Gy electron beam irradiation, it does not significantly change the 277 
strain’s activity against K. pneumoniae, and the viability of the commercial strain from Lacto-G 278 
(a marketed synbiotic formulation), Lactobacillus acidophilus DDS®-1, dropped by up to 5%. 279 
Further investigations indicated that 50-150 Gy electron beam irradiation may increase the 280 
biofilm formation ability L. rhamnosus Vahe without changing cell surface hydrophobicity levels 281 
[40].  282 
Current investigations revealed the different impacts of seventeen probiotic lactobacilli strains on 283 
irradiated rats’ mortality and blood characteristics (data are not provided). In particular, L. 284 
rhamnosus Vahe and L. delbrueckii IAHAHI positively affected these characteristics of 285 
irradiated rats in vivo. We found no differences between the effects of L. rhamnosus Vahe and its 286 
CFS on the survival and blood characteristics of irradiated animals. This, most likely, indicates 287 
the role of CFS in the radio-preventive activities of the probiotic. The feeding of rats with L. 288 
rhamnosus Vahe or CFS before irradiation positively affected the rats’ survival and blood WBC 289 
count, while there were no statistically significant differences in these physiological parameters 290 
for probiotic/CFS feeding after the rats’ irradiation. Interestingly, the potential probiotic L. 291 
delbrueckii IAHAHI showed positive effects when the rats were fed after the irradiation, while 292 
there were no detectable positive effects of probiotic supplementation for the rats fed before the 293 
irradiation. 294 
X-ray and similar forms of irradiation (such as electron beam radiation) are commonly used 295 
during radiotherapy to treat disease. The body may release extra sugar immediately after 296 
radiotherapy to help cells survive the treatment resulting in an increase in the host’s BGL. 297 
Normal glucose levels in blood differ between rodents and humans. Fasting glucose levels 298 
between 100 and 199 mg/dL are common among mouse strains, even after treatment with a high-299 
fat diet. This range is not typically associated with diabetic symptoms such as polyuria and 300 
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polydipsia. Diabetes in rodents is defined as a fasting glucose level >250 mg/dL [41]. The 301 
feeding cannula for seven days by the putative probiotic L. rhamnosus Vahe (as well as by its 302 
CFS) prior to irradiation with 4.5-20 Gy X-ray significantly increased the viability of rats 303 
without any side effects on experimental animals’ BGL. But, the feeding of rats by L. rhamnosus 304 
strain Vahe after irradiation had no significant effect (the results are not given). At the same 305 
time, the results on the impact of L. delbrueckii IAHAHI on rats’ BGLs indicates the possibility 306 
for the use of this probiotic strain by patients with type 2 diabetes. 307 
The beneficial activities of probiotics most likely result from complex interactions of the bacteria 308 
with the intestinal microflora and the host gut epithelium [42]. Among several proposed 309 
mechanisms by which probiotics mediate their effects is modulation of the innate immune 310 
response, which may be anti-inflammatory [43, 44] or pro-inflammatory in nature [15]. 311 
Furthermore, probiotic bacteria have been shown to enhance the adaptive immune response and 312 
antibody formation [45, 46]. Inhibition of the adherence of attaching and effacing organisms 313 
[47], modulation of mucosal barrier function [48], or inhibition of neutrophil migration [49] may 314 
also be important mechanisms whereby probiotics might impact intestinal diseases [50]. There is 315 
also strong evidence that the signaling molecules or determinants are preserved in probiotic 316 
strains [51], and certain probiotic strains are able to enhance immune function, especially in 317 
subjects with less than adequate immune function [52]. Potential radioprotectors might include 318 
the vitamins produced by probiotics [22], which may also exert immunomodulatory effects as 319 
well [26]. Interestingly, vitamins might also have different pre- and post-treatment effects [27]. 320 
Current investigations show that L. rhamnosus Vahe and L. delbrueckii IAHAHI, as well as the 321 
probiotic strain L. plantarum ZPZ with neutral radio-protective activities, are potential producers 322 
of water-soluble riboflavin, biotin, folate, and pyridoxine; with different numbers of genes that 323 
might be engaged in vitamin production between these bacteria.  324 
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It is known that riboflavin, necessary for cellular respiration, also participates in tryptophan - 325 
niacin conversation, while biotin supports the metabolism of fats, proteins, and carbohydrates 326 
from food [53]. Folic acid, an active participant in protein metabolism and in the promotion of 327 
red blood cell formation [54], is able to fight against oxidative stress in the rat colon [55] and 328 
may prevent elevated DNA damage rates and altered methylation of DNA, which are important 329 
risk factors in cancer [56, 57]. Besides the participation in protein metabolism and promotion of 330 
red blood cell formation, pyridoxine, another vitamin, also participates in the production of 331 
insulin, the protection against oxidative stress in human erythrocytes [58, 59], and from ionizing 332 
radiation-induced apoptosis in the intestinal epithelium [60]. It is possible that the production of 333 
vitamins mentioned in this study (Figure 7) plays a role in determining the “radio-protective” 334 
characteristics of L. delbrueckii IAHAHI and L. rhamnosus Vahe. For example, according to 335 
current whole-genome sequencing, L. delbrueckii IAHAHI is a potential producer of thiamine, 336 
vital for a functioning nervous system, and might participate in the “recovery of post-radiation 337 
physiology” of irradiated rats through thiamine’s action [61]. In addition, pyridoxine, the 338 
production of which by L. delbrueckii IAHAHI is likely more pronounced than in the other two 339 
strains: L. plantarum ZPZ and L. rhamnosus Vahe, could have an effect on the “lowering” of 340 
rats’ BGLs. On the other hand, L. rhamnosus Vahe and L. plantarum ZPZ are able to produce 5-341 
FCL like protein, a participant of the one-carbon pool by folate [62]; It is possible that this and 342 
the strains’ heme biosynthesis ability, which might lead to heme exerting damaging effects after 343 
the rats’ radiation [63], might limit the potential “radio-protective” role of probiotics in the post-344 
radiation period. 345 
Previously the effects of these three investigated lactobacilli strains on DNA damages in the 346 
small intestine of Wistar rats in vivo were discussed [20]. Lactobacilli genes involved in 347 
riboflavin, FMN, and FAD metabolism and the production of flavodoxin (Figure 7) might 348 
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participate in the alleviation of DNA damages in the small intestine of rats, thereby providing 349 
resistance to irradiation in these animals. At the same time, the effects of probiotics on irradiated 350 
rats might be explained by the possible neutralization of the destructive influence of irradiation 351 
on rats, mostly affecting activated free radical processes in the intestines and in the organism as a 352 
whole. Interestingly, experiments have shown that the investigated lactobacilli strains were 353 
different in their hydrogen peroxidase and catalase activity. According to full genome analysis, 354 
L. delbrueckii IAHAHI carries a hydrogen peroxide-inducible gene activator that is not present 355 
in the other investigated strains. Hydrogen peroxidase and catalase activities of these lactobacilli 356 
were investigated experimentally; the data confirmed the results of the full genome analysis.  357 
However, all discussion related to the vitamins’ potential effects are hypothetical and need 358 
experimental confirmation; future investigations on these probiotics` metabolites will further 359 
promote the understanding of the mechanisms underlying their radio-protective effects. 360 
 361 
Conclusion 362 
In this study, we determined the potential of these probiotic strains for radio-preventive and 363 
radio-protective purposes and found the effect to be dependent on differences in the hosts’ 364 
physiologic state before and after the irradiation, affecting the probiotic’s potential impact. These 365 
findings are also of significance for L. rhamnosus Vahe/its CFS and L. delbrueckii IAHAHI and 366 
their potential application as starters for the production of functional food with radio-protective 367 
activities.  368 
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Note: * Cell free supernatant  581 
Figure 1. The experimental rats’ groups.   582 
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Table 1. White blood cells’ numbers and mortality of rats after the 7 days of irradiation*: the 583 




































* In blankets - percentage of the number of alive rats after the seventh day of irradiation. 
P1 - comparison with the untreated rats. 
P2 - comparison with the control rats (Group 1; Figure 1). 
 586 
  587 
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Table 2. Rats’ blood glucose levels (mM/L) after 7 day of 4.5 Gy irradiation: the impact of 588 
probiotic L. rhamnosus Vahe. 589 
 590 
  591 
 Control 
untreated rats,  
N = 8 
Placebo 
rats, 
N = 8 
Irradiated 
rats,   
N = 8 
control-
probiotic,  
N = 8 
Prevention-
probiotic*,  
N = 8 
Blood 
glucose 
7.26 ± 0.19 6.73 ± 0.33 
P>0.05 
6.735 ± 0.29 
P>0.05 
8.119 ± 0.2 
P<0.05 
7.707 ± 0.16  
P>0.05 
Note:  
* These rats were fed during 7 days by probiotic Vahe prior to irradiation.  
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Table 3. Rats’ blood glucose levels (mM/L) after 7 days of 4.5 Gy irradiation: impact of L. 592 









N = 8 
Placebo 
rats, 
N = 8 
Irradiated 
rats, 
N = 8 
control-
probiotic, 
N = 8 
Prevention-
probiotic*, 
N = 8 
Blood glucose 7.26 ± 0.19 6.73 ± 0.33 
P>0.05 




7.62 ± 0.54 
P>0.05 
Note:  
* These rats were fed during 7 days by probiotic IAHAHI after the irradiation.  
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Table 4. Genome characteristics of lactobacilli. 599 
 600 
 601 
*This strain did not protect against 4.5 - 20 GY radiation. 602 
**Values for genome sequences of other strains of the respective species. 603 























43 32.7x 413,896 1,766,423 1.73-2.26 49.8 49.1-50.1 
L. rhamnosus 
Vahe 
34 56.5x 722,392 2,834,560 2.59-3.11 46.7 46.6-46.8 
L. plantarum 
ZPZ* 




Figure 2. Dose-viability relationship for in vivo experiments on male Wistar rats. Whole body 606 
X-ray irradiation was performed using RUM-17 therapeutic X-ray unit, Russia (technical 607 
specifications- dose levels: 5.5 Gy, 12.5 Gy and 20 Gy, dose rate: 1.43 Gy/min, height of a X-ray 608 
tube over an object:  50 cm, current: 15 mA, 180 kV and exposition time:  3.85 min, 8.74 min 609 
and 13.99 min accordingly.  610 
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Figure 3. Effects of Lactobacillus rhamnosus Vahe and its cell free supernatant on viability of 613 
whole body 5.5 Gy single-dose X-ray irradiated male Wistar rats. Whole body X-ray irradiation 614 
was performed using RUM-17 therapeutic X-ray unit, Russia (technical specifications: dose 615 
levels: dose rate: 1.43 Gy/min, height of a X-ray tube over an object:  50 cm, current: 15 mA, 616 
180 kV and exposition time:  3.85 min. The mortality of rats was provided for the following 617 
seven days after the irradiation. 618 

















CFS, feeding before 
irradiation
Probiotic, feeding   
before irradiation
CFS, feeding before and 
after irradiation





Figure 4. Effects of cell free supernatant (CFS) of the probiotic Lactobacillus rhamnosus Vahe 621 
on viability of whole body 12.5 Gy and 20 Gy single-dose X-ray irradiated Wistar rats. Whole 622 
body X-ray irradiation was performed using RUM-17 therapeutic X-ray unit, Russia (technical 623 
specifications- dose levels: 12.5 Gy and 20 Gy, dose rate: 1.43 Gy/min, height of a X-ray tube 624 
over an object:  50 cm, current: 15 mA, 180 kV and exposition time:  8.74 min and 13.99 min 625 
accordingly. The rats were fed by the cell free supernatant during the seven days prior to 626 
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  634 
Figure 5. Dose-viability effects of 5.5 Gy - 20 Gy irradiation in seventh day after the X-ray 635 
irradiation. Whole body X-ray irradiation was performed using RUM-17 therapeutic X-ray unit, 636 
Russia (technical specifications- dose levels: 5.5 Gy, 12.5 Gy and 20 Gy, dose rate: 1.43 Gy/min, 637 
height of a X-ray tube over an object:  50 cm, current: 15 mA, 180 kV and exposition time:  3.85 638 
min, 8.74 min and 13.99 min accordingly. The rats were fed by the probiotic L. delbrueckii 639 






























Figure 6. The rats’ in seventh day of 4.5 Gy irradiation: impact of L. delbrueckii IAHAHI. The 645 
rats were fed by the probiotic L. delbrueckii IAHAHI during the following seven days after the 646 
irradiation. 647 


































Figure 7. Comparison of subsystem features of the putative probiotic strains Lactobacillus 653 
rhamnosus Vahe, Lactobacillus delbrueckii IAHAHI and Lactobacillus plantarum ZPZ: 654 
vitamins and cofactors. 655 




Heme and siroheme biosynthesis
Riboflavin to FAD
Flavodoxin
Riboflavin, FMN and FAD metabolism
Pyridoxin (Vitamin B6) biosynthesis
Pyridoxin (Vitamin B6)- degradation pathway








Subsystem Feature Categories L. plantarum ZPZ
L. rhamnosus Vahe
L. delbrueckii IAHAHI
Table. Characteristics of lactobacilli. 
 Species  Sources  
Probiotic’s effects on white 
blood cells’ counts* 
Probiotic’s 
administratio





n: after the 
rats’ 
irradiation 





2 Lactobacillus delbrueckii subsp. bulgaricus  sheep gut 
microbiota 
Ab Ab 





4 L. casei sheep’s 
milk 
- Ab 





6 L. fermentum sheep’s 
milk 
Ab - 




Ab  Ab 
8 L. paracasei sheep’s 
milk 
- Ab 
9 L. plantarum sheep’s 
milk 
- Ab 
10 L. plantarum ZPZ V  breastfeedi
ng girl 
Ab  Ab 
11 L. rhamnosus Vahe  breastfeedi
ng boy 
Ab +++ 
12 L. rhamnosus  sheep gut 
microbiota 
Ab + 
13 L. crispatus breastfeedi
ng boy 
--- Ab 
14 L. helveticus  breastfeedi
ng boy 
- Ab 
15 L. helveticus sheep gut 
microbiota 
Ab Ab 
16 L. acidophilus DDS®-1  human 
origin 
Ab - 
17 probiotic Narine  human 
origin 
- Ab 
*Comparison with the control 4.5 Gy irradiated rats (Group 2.1; Picture 1) 
Ab- Absence of valid differences between the research data for probiotic’s and control group rats. 
+++ Maximal positive effect 
+ low effect 
---Maximal negative effect 
-low negative effect  
V- This strain was used as a “control” to compare full genomic analysis on vitamins of the strains 
with radio-preventive/-protective due to its neutral radio-protective/-preventive activities. Also, L. 
plantarum ZPZ is one of the probiotic strains having high antagonistic activities against 
nosocomial pathogens from the Yerevan hospitals. 
 
